Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US

    It’s not often thought about but as we get older, our verbal capabilities deteriorate with age and for some, this can have a drastic impact on their health when unable to communicate the state of their wellbeing. Such issues for those who are non-verbal due to neurodegenerative diseases, however, may soon be solved for those

    Read More
    Public
  • NobleOak acquires RevTech and FiftyUp Club in $11 million deal that ceases life insurance commission payments
    • News

    NobleOak acquires RevTech and FiftyUp Club in $11 million deal that ceases life insurance commission payments

    NobleOak Life (ASX: NOL) has acquired the trailing commissions and FiftyUp Club platform business from RevTech Media Pty Ltd, in a deal valued at $11 million. The acquisition strengthens NobleOak’s position in the Australian life insurance market by granting the Company access to a significant member base and eliminating ongoing commission payments. RevTech, a media

    Read More
    Public
  • Mosaic Brands to shut down five clothing brands and corresponding stores in a bid for survival
    • News

    Mosaic Brands to shut down five clothing brands and corresponding stores in a bid for survival

    Battling to keep the doors open at its flagship Noni B, Katies, Millers and Rivers stores, specialty fashion retail Mosaic Brands (ASX: MOZ) will shutter five of its brands in a drastic move to simplify its business and secure its financial future. All retail and online stores associated with Rockmans, Autograph, Crossroads, W.Lane, and BeMe will

    Read More
    Public
  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use

    It may only be a matter of time until expectant mothers can monitor the heartbeats of their unborn child from home with medtech company HeraMed (ASX: HMD) pursuing regulatory reclassification to enable their HeraBEAT device to be reinstated for commercial distribution.  HeraMED is advancing discussions with the Therapeutic Goods Administration (TGA) to reinstate its HeraBEAT

    Read More
    Public
  • ClearVue ventures into net-zero modular housing market with Prefabulous
    • News

    ClearVue ventures into net-zero modular housing market with Prefabulous

    With soaring energy prices, it comes as no surprise that more households are seeking to reduce their carbon footprint by optimising their houses are downscaling entirely, a trend being capitalised on by solar glass company ClearVue Technologies (ASX: CPV) through a new collaboration with modular housing manufacturer, Prefabulous.  The partnership will see ClearVue’s solar glazing

    Read More
    Public
  • Ecofibre secures deal to supply Under Armour with eco-friendly yarn alternative to spandex
    • News

    Ecofibre secures deal to supply Under Armour with eco-friendly yarn alternative to spandex

    The trend of casual activewear has done wonders for many apparel companies around the world, but it’s also come at a cost due to the scarcity of materials that are both stretchy and durable. Tackling this, sustainable materials company Ecofibre (ASX: EOF) has been engaged by sportswear giant Under Armour through a major supply agreement

    Read More
    Public
  • «
  • ‹
  • 30
  • 31
  • 32
  • 33
  • 34
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.